Ownership

Hans Hull - Insider Trading & Ownership

Entity: Individual
Location: C/O Avalanche Biotechnologies, Inc., 1035 O'brien Drive, Suite A, Menlo Park, CA
Summary: The estimated net worth of Hans Hull is at least $2.92M dollars as of January 27, 2025. Hans Hull is the Chief Business Officer of PLIANT THERAPEUTICS, INC. and owns shares of PLIANT THERAPEUTICS, INC. (PLRX) stock worth about $2.92M.
All Insider Reports: All Insider Reports

Ownership of Hans Hull

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
PLRX	PLIANT THERAPEUTICS, INC.	Chief Business Officer	$2.92M	-$293K	-9.12%	Jan 23, 2025

Insider Transactions Reported by Hans Hull:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.